Sexual Function in High-risk Pregnant Women
Sponsor
Karabuk University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06130150
Collaborator
(none)
400
1
29.7
13.5
Study Details
Study Description
Brief Summary
Our aim with this study is to evaluate the sexual functions of pregnant women whose pregnancies are defined as high-risk pregnancies and whose pregnancies are followed by perinatology specialists.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
400 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Evaluation of Sexual Function in High-risk Pregnant Women
Actual Study Start Date
:
Jul 10, 2021
Actual Primary Completion Date
:
Jan 10, 2022
Anticipated Study Completion Date
:
Jan 1, 2024
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
High-risk This group includes pregnant women with the risk factors determined in the study |
|
Normal This group includes pregnant women with no risk |
Outcome Measures
Primary Outcome Measures
- 1 [1 day]
High-risk pregnant women have lower FSFI score results then normal pregnant women
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria: - Pregnant women over 18 years old, -Pregnant women 39 years old and under, -Pregnant women in their 3rd trimester.
Exclusion Criteria: - Pregnant women under 18 years old, -Pregnant women over 40 years old, -Pregnant women in their 1st or 2nd trimester.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Prof. Dr. Cemil Tascioglu City Hospital | Istanbul | Sisli | Turkey | 34384 |
Sponsors and Collaborators
- Karabuk University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Cagdas Nurettin Emeklioglu,
MD,
Karabuk University
ClinicalTrials.gov Identifier:
NCT06130150
Other Study ID Numbers:
- KBU-EMEKLIOGLU-002
First Posted:
Nov 14, 2023
Last Update Posted:
Nov 14, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cagdas Nurettin Emeklioglu,
MD,
Karabuk University